Ticker LaunchReverse merger · Completed · TMBR
Timber Pharmaceuticals LLC
Reverse merger with BioPharmX Corporation (BPMX)
Timber Pharmaceuticals LLC merged into BioPharmX Corporation (BPMX), a NYSE American-listed specialty pharmaceutical company, in a reverse merger that takes the private company public. The deal was announced on Jan 28, 2020 and closed on May 18, 2020. The combined company trades as Timber Pharmaceuticals, Inc. (TMBR) on NYSE American.
Timber Pharmaceuticals is a biopharmaceutical company developing treatments for orphan dermatologic diseases, with two product candidates in Phase 2b clinical trials. It became public by merging Timber Pharmaceuticals LLC into BioPharmX.
- Status
- Completed
- Private company
- Timber Pharmaceuticals LLC
- Public company
- BioPharmX Corporation (BPMX)
- Public company business before
- NYSE American-listed specialty pharmaceutical company
- Announced
- Jan 28, 2020
- Closed
- May 18, 2020
- Combined company
- Timber Pharmaceuticals, Inc. (TMBR)
- Exchange
- NYSE American
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other completed reverse mergers
- AYRO, Inc. (AYRO Operating Company)into DropCar, Inc. · May 28, 2020
- Chondrial Therapeutics, Inc.into Zafgen, Inc. · May 28, 2020
- Histogen Inc.into Conatus Pharmaceuticals Inc. · May 26, 2020
- Qualigen, Inc.into Ritter Pharmaceuticals, Inc. · May 22, 2020
- Forta Financial Group, Inc.into Financial Gravity Companies, Inc. · May 21, 2020
- GPS Associates, Inc.into Mountain High Acquisitions Corp. · May 13, 2020